Some researchers suggested that GnRH-a and hCG dual trigger might be associated with improvements in clinical outcomes, involving clinical pregnancy rate and live birth rate per transfer, but the risk of OHSS remains unclear [13, 14]. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.